HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
HARROW, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$27.68+0.40 (+1.47%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
Harrow statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Harrow | Industry median |
|---|---|---|
| Market Cap | $1.04B | $197.05M |
| Enterprise Value | $1.25B | $106.56M |
| PS Ratio | 3.77 | 3.93 |
| PB Ratio | 68.27 | 2.14 |
| P/FCF Ratio | 206.87 | 18.25 |
| P/OCF Ratio | 165.97 | 13.78 |
Enterprise value
| Measure | Harrow | Industry median |
|---|---|---|
| EV / Sales | 4.52 | 2.69 |
| EV / FCF | 248.37 | 21.02 |
Income (trailing twelve months)
| Measure | Harrow | Industry median |
|---|---|---|
| Revenue | $275.59M | $57.94M |
| Gross Profit | $201.96M | $90.47M |
| Operating Income | -$2.75M | -$21.44M |
| Pretax Income | -$33.43M | -$14.45M |
| Net Income | -$37.23M | -$22.46M |
| EBITDA | -$1.18M | -$16.91M |
| EPS (Diluted) | -$0.99 | -$0.83 |
Margins
| Measure | Harrow | Industry median |
|---|---|---|
| Gross Margin | 73.3% | 52.3% |
| Operating Margin | -1.00% | -44.5% |
| Pretax Margin | -12.1% | -13.0% |
| Profit Margin | -13.5% | -39.2% |
| EBITDA Margin | -0.43% | -31.3% |
| FCF Margin | 1.82% | -8.85% |
Returns
| Measure | Harrow | Industry median |
|---|---|---|
| Return on Equity (ROE) | -114.8% | -53.1% |
| Return on Assets (ROA) | -9.77% | -41.0% |
| Return on Invested Capital (ROIC) | -1.68% | -32.0% |
| Return on Capital Employed (ROCE) | -0.87% | -37.8% |
Growth
| Measure | Harrow | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 21.1% | 6.01% |
| FCF Growth (YoY) | 97.3% | 2.34% |
| Revenue Growth (3Y CAGR) | 45.4% | 2.25% |
| Revenue Growth (5Y CAGR) | 41.0% | 6.42% |
Balance sheet
| Measure | Harrow | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $83.89M | $62.42M |
| Total Debt | $292.38M | $120.13M |
| Net Cash (Debt) | -$208.49M | $15.68M |
| Net Cash Per Share | -$5.56 | $0.65 |
| Equity (Book Value) | $15.20M | $48.79M |
| Book Value Per Share | $0.41 | $1.36 |
| Tangible Book Value | -$160.70M | $23.06M |
| Working Capital | $127.14M | $75.77M |
Financial position
| Measure | Harrow | Industry median |
|---|---|---|
| Current Ratio | 2.24 | 3.30 |
| Quick Ratio | 1.98 | 2.39 |
| Debt / Equity | 19.24 | 0.51 |
| Debt / FCF | 58.29 | 5.05 |
| Interest Coverage | -0.12 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Harrow | Industry median |
|---|---|---|
| Operating Cash Flow | $6.25M | -$12.35M |
| Capital Expenditures | -$1.24M | -$1.06M |
| Free Cash Flow | $5.02M | -$20.28M |
| FCF Per Share | $0.13 | -$0.41 |
Efficiency
| Measure | Harrow | Industry median |
|---|---|---|
| Asset Turnover | 0.72 | 0.38 |
| Inventory Turnover | 5.17 | 2.67 |
| Revenue Per Employee | $738.86K | $398.96K |
| Profits Per Employee | -$99.80K | -$732.08K |
| Employee Count | 373 | 73 |
Dividends and yields
| Measure | Harrow | Industry median |
|---|---|---|
| Earnings Yield | -3.59% | -21.2% |
| FCF Yield | 0.48% | -7.64% |
Shares
| Measure | Harrow | Industry median |
|---|---|---|
| Shares Outstanding | 37,487,900 | 59,128,900 |
| Shares Change (YoY) | 3.11% | 11.1% |
| Shares Change (QoQ) | 0.58% | 0.54% |
| Float | 32,146,800 | 48,744,500 |
| Shares Held by Insiders | 14.2% | 11.8% |
| Shares Held by Institutions | 57.4% | 59.4% |
Scores
| Measure | Harrow | Industry median |
|---|---|---|
| Altman Z-Score | 1.88 | 0.10 |
| Piotroski F-Score | 5 | 4 |
| Beneish M-Score | -3.05 | -2.62 |
Calculated by StockData from Harrow's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.